1. Serum and Pleural Soluble Cell Adhesion Molecules in Mesothelioma Patients: A Retrospective Cohort Study
   Sofia Tsagkouli et al, 2022, Cancers CrossRef
2. The Effects of Standard Anthracycline-Based Chemotherapy on Soluble ICAM-1 and Vascular Endothelial Growth Factor Levels in Breast Cancer
   Paul J. Mills et al, 2004, Clinical Cancer Research CrossRef
3. The Predictive Role of Serum Levels of Soluble Cell Adhesion Molecules (sCAMs) in the Therapy of Advanced Breast Cancer—A Single-Centre Study
   Weronika Bulska-Będkowska et al, 2022, Medicina CrossRef
4. Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non–Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab—an Eastern Cooperative Oncology Group Study
   Afshin Dowlati et al, 2008, Clinical Cancer Research CrossRef
5. Relationship between Serum Soluble Vascular Adhesion Protein-1 Level and Gastric Cancer Prognosis
   Muhammet A. Kaplan et al, 2014, Oncology Research and Treatment CrossRef
6. Phase II Trial of Bevacizumab in Combination with Weekly Docetaxel in Metastatic Breast Cancer Patients
   Bhuvaneswari Ramaswamy et al, 2006, Clinical Cancer Research CrossRef
7. Improvement of Glycemic Control by 1 Year of Insulin Therapy Leads to a Sustained Decrease in sE-Selectin Concentrations in Type 2 Diabetes
   Leena Ryysy et al, 2001, Diabetes Care CrossRef
8. A Vasculature-Targeting Regimen of Preoperative Docetaxel with or without Bevacizumab for Locally Advanced Breast Cancer: Impact on Angiogenic Biomarkers
   Joseph Baar et al, 2009, Clinical Cancer Research CrossRef